{"id":34431,"date":"2015-04-30T19:45:00","date_gmt":"2015-04-30T17:45:00","guid":{"rendered":"http:\/\/www.diabsite.de\/diabetes-weblog\/?p=34431"},"modified":"2015-05-01T20:54:47","modified_gmt":"2015-05-01T18:54:47","slug":"typ-2-diabetes","status":"publish","type":"post","link":"https:\/\/www.diabsite.de\/diabetes-weblog\/2015\/04\/30\/typ-2-diabetes\/","title":{"rendered":"Typ-2-Diabetes"},"content":{"rendered":"<p>Beratergremium der US-Amerikanischen Arzneibeh\u00f6rde empfiehlt Warnhinweise zu Herzschw\u00e4che durch 2&nbsp;Diabetesmedikamente: Am 13.&nbsp;April&nbsp;2015 empfahl das Advisory Board der FDA, in die Produktinformationen von Saxagliptin (Onglyza, AstraZeneca) und Alogliptin (Nesina, Takeda) Warnhinweise zur kardiovaskul\u00e4ren Sicherheit aufzunehmen. <a href=\"https:\/\/www.diabsite.de\/aktuelles\/nachrichten\/2015\/150430b.html\" target=\"_blank\" class=\"ds\" title=\"zur Nachricht (neues Fenster)\">Nachricht lesen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beratergremium der US-Amerikanischen Arzneibeh\u00f6rde empfiehlt Warnhinweise zu Herzschw\u00e4che durch 2&nbsp;Diabetesmedikamente: Am 13.&nbsp;April&nbsp;2015 empfahl das Advisory Board der FDA, in die Produktinformationen von Saxagliptin (Onglyza, AstraZeneca) und Alogliptin (Nesina, Takeda) Warnhinweise zur kardiovaskul\u00e4ren Sicherheit aufzunehmen. Nachricht lesen<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[1826,240,92,4842,4843],"_links":{"self":[{"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/posts\/34431"}],"collection":[{"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/comments?post=34431"}],"version-history":[{"count":3,"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/posts\/34431\/revisions"}],"predecessor-version":[{"id":34436,"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/posts\/34431\/revisions\/34436"}],"wp:attachment":[{"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/media?parent=34431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/categories?post=34431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.diabsite.de\/diabetes-weblog\/wp-json\/wp\/v2\/tags?post=34431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}